Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

2011

4001 ARTíCULOS , VIENDO DEL 61 AL 75

PUBMED

Role of matrix metalloproteinase-9 (MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease.

Duran-Vilaregut J, del Valle J, Manich G, Camins A, Pallàs M, Vilaplana J, Pelegrí C.

Neuropathol Appl Neurobiol. 2011 Aug;37(5):525-37. doi: 10.1111/j.1365-2990.2010.01157.x.

0

0

0

PUBMED

Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials.

Freed CR, Zhou W, Breeze RE.

Neurotherapeutics. 2011 Oct;8(4):549-61. doi: 10.1007/s13311-011-0082-9. Review.

0

0

0

PUBMED

The effect of Parkinson's-disease-associated mutations on the deubiquitinating enzyme UCH-L1.

Andersson FI, Werrell EF, McMorran L, Crone WJ, Das C, Hsu ST, Jackson SE.

J Mol Biol. 2011 Mar 25;407(2):261-72. doi: 10.1016/j.jmb.2010.12.029.

0

0

0

PUBMED

Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration.

Furrer SA, Mohanachandran MS, Waldherr SM, Chang C, Damian VA, Sopher BL, Garden GA, La Spada AR.

J Neurosci. 2011 Nov 9;31(45):16269-78. doi: 10.1523/JNEUROSCI.4000-11.2011.

0

0

0

PUBMED

The effect of age on motor deficits and cerebral glucose metabolism of Parkinson's disease.

Lee MS, Lyoo CH, Ryu YH, Lim HS, Nam CM, Kim HS, Rinne JO.

Acta Neurol Scand. 2011 Sep;124(3):196-201. doi: 10.1111/j.1600-0404.2010.01446.x.

0

0

0

PUBMED

Clinical Significance of F-18 FP-CIT Dual Time Point PET Imaging in Idiopathic Parkinson's Disease.

Oh JK, Yoo ID, Seo YY, Chung YA, Yoo IeR, Kim SH, Song IU.

Nucl Med Mol Imaging. 2011 Dec;45(4):255-60. doi: 10.1007/s13139-011-0110-z.

0

0

0

PUBMED

Difficulties with neurological prognostication in a young woman with delayed-onset generalised status myoclonus after cardiac arrest due to acute severe asthma.

Rajamani A, Seppelt I, Bourne J.

Indian J Crit Care Med. 2011 Apr;15(2):137-9. doi: 10.4103/0972-5229.83010.

0

0

0

PUBMED

Distribution of Na/K-ATPase alpha 3 isoform, a sodium-potassium P-type pump associated with rapid-onset of dystonia parkinsonism (RDP) in the adult mouse brain.

Bøttger P, Tracz Z, Heuck A, Nissen P, Romero-Ramos M, Lykke-Hartmann K.

J Comp Neurol. 2011 Feb 1;519(2):376-404. doi: 10.1002/cne.22524.

0

0

0

PUBMED

Imaging biomarkers in Parkinson's disease.

Brooks DJ, Pavese N.

Prog Neurobiol. 2011 Dec;95(4):614-28. doi: 10.1016/j.pneurobio.2011.08.009. Review.

0

0

0

PUBMED

Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy.

Usui C, Hatta K, Doi N, Kubo S, Kamigaichi R, Nakanishi A, Nakamura H, Hattori N, Arai H.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1704-8. doi: 10.1016/j.pnpbp.2011.05.003.

0

0

0

PUBMED

Pre-fibrillar α-synuclein mutants cause Parkinson's disease-like non-motor symptoms in Drosophila.

Gajula Balija MB, Griesinger C, Herzig A, Zweckstetter M, Jäckle H.

PLoS One. 2011;6(9):e24701. doi: 10.1371/journal.pone.0024701.

0

0

0

PUBMED

Prepulse inhibition of the startle reflex for differentiation of enuresis in children.

Meir J, Eggert P.

Pediatr Nephrol. 2011 Jun;26(6):939-43. doi: 10.1007/s00467-011-1817-x.

0

0

0

PUBMED

Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.

Foulds PG, Mitchell JD, Parker A, Turner R, Green G, Diggle P, Hasegawa M, Taylor M, Mann D, Allsop D.

FASEB J. 2011 Dec;25(12):4127-37. doi: 10.1096/fj.10-179192.

0

0

0

PUBMED

Dream features in the early stages of Parkinson's disease.

Bugalho P, Paiva T.

J Neural Transm (Vienna). 2011 Nov;118(11):1613-9. doi: 10.1007/s00702-011-0679-5.

0

0

0

PUBMED

Highly potent activity of (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in animal models of Parkinson's disease.

Ardashov OV, Pavlova AV, Il'ina IV, Morozova EA, Korchagina DV, Karpova EV, Volcho KP, Tolstikova TG, Salakhutdinov NF.

J Med Chem. 2011 Jun 9;54(11):3866-74. doi: 10.1021/jm2001579.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy